CACNA1C and Ventricular hypertrophy: Mutations in CACNA1C, which encodes CaV1.2, result in the pathogenesis of atrial fibrillation [5], ventricular fibrillation [6], hypertrophic cardiomyopathy [7] and ventricular hypertrophy [8].